Constellation Pharmaceuticals' Series B Round

Constellation Pharmaceuticals raised a round of funding on August 19, 2009.

Constellation Pharmaceuticals (NASDAQ: CNST) is a biopharmaceutical company dedicated to the development of therapeutics in the emerging field of Epigenetics, a new field of science involving selectiv…

Articles about Constellation Pharmaceuticals' Series B Round: